Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.01 USD
Change Today +0.15 / 1.52%
Volume 2.9M
ACHN On Other Exchanges
As of 5:20 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - achillion pharmaceuticals (ACHN)

NameBoard RelationshipsTitleAge
Milind S. Deshpande Ph.D.20 RelationshipsChief Executive Officer, President and Director57
Mary Kay Fenton No RelationshipsChief Financial Officer, Executive Vice President and Secretary50
David Apelian M.D., Ph.D., MBANo RelationshipsChief Medical Officer and Executive Vice President49
Kevin Kucharski No RelationshipsSenior Vice President of Clinical Operations--
Joseph Truitt No RelationshipsChief Commercial Officer and Executive Vice President of Business Development49

Board Members - achillion pharmaceuticals (ACHN)

NameBoard RelationshipsPrimary CompanyAge
David I. Scheer 42 RelationshipsTengion, Inc.61
Milind S. Deshpande Ph.D.20 RelationshipsAchillion Pharmaceuticals, Inc.57
Michael D. Kishbauch 42 RelationshipsAchillion Pharmaceuticals, Inc.65
Robert L. Van Nostrand BS40 RelationshipsMetabolix, Inc.57
Gary E. Frashier M.B.A., P.E.20 RelationshipsManagement Associates77

Executive Committees* - achillion pharmaceuticals (ACHN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeRobert L. Van Nostrand BS 40 Relationships3 Executives
Compensation CommitteeGary E. Frashier M.B.A., P.E. 20 Relationships4 Executives
Nominating CommitteeDavid I. Scheer 42 Relationships2 Executives
Corporate Governance CommitteeDavid I. Scheer 42 Relationships2 Executives
Management/Organization Development CommitteeMichael D. Kishbauch 42 Relationships4 Executives
View ACHN Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $10.01 USD +0.15

ACHN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,641 GBp +14.00
Bavarian Nordic A/S kr356.50 DKK -0.50
Bayer AG €141.15 EUR +1.79
Chimerix Inc $37.32 USD -0.37
Emergent Biosolutions Inc $29.46 USD +0.70
View Industry Companies

Industry Analysis


Industry Average

Valuation ACHN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 7.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at